Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease-Reference-Cited by-同舟云学术

Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease

Published:1997-10 Issue:4 Volume:42 Page:613-621
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Schiffmann Raphael,Heyes Melvyn P.,Aerts J. M.,Dambrosia James M.,Patterson Marc C.,DeGraba Thomas,Parker Colette C.,Zirzow Gregory C.,Oliver Katherine,Tedeschi Gioacchino,Brady Roscoe O.,Barton Norman W.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference45 articles.

1. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.

2. Gaucher disease. In: eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995: 2641-2670

3. Non-infantile neuronopathic Gaucher's disease: A clinicopathologic study

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases;Proceedings of the National Academy of Sciences;2024-08-16

2. Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3;Molecular Genetics and Metabolism;2024-08

3. Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease;Orphanet Journal of Rare Diseases;2022-06-18

4. Progressive Myoclonic Epilepsies;Handbook of the Cerebellum and Cerebellar Disorders;2021-12-05

5. Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy;Glia;2021-04-14